• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

5
2
1
1
1

COUNTRY

1
1

CATEGORIES

  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

0
2
2
7

PUBLISHED

0
0
3
7

PRODUCT TYPE

7

Search "Pricing and Reimbursement Risk and Opportunities in Pharmaceutical Deal Making" returned 7 results.

PRODUCT TITLE

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily...

April 2013
FROM

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy This linkage could be important in the therapeutic...

February 2012
FROM
Emerging Markets Collection Emerging Markets Collection - Product Thumbnail Image

Emerging Markets Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM
Generics/Biosimilars Collection Generics/Biosimilars Collection - Product Thumbnail Image

Generics/Biosimilars Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM
Marketing Collection Marketing Collection - Product Thumbnail Image

Marketing Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM

Executive Report on Strategies in Switzerland

How to Strategically Evaluate Switzerland Perhaps the most efficient way of evaluating Switzerland is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio...

June 2007

Executive Report on Strategies in Spain

How to Strategically Evaluate Spain Perhaps the most efficient way of evaluating Spain is to consider key dimensions which themselves are composites of multiple factors. Composite portfolio approaches...

June 2007
Loading Indicator